This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

The Pall XRS 20 Bioreactor System's Unique Bi-axial Agitation Properties Improve Cell Culture Performance. (Photo: Business Wire)

Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today introduced the XRS 20 Bioreactor System, a new bioreactor with unique agitation properties that incorporates a single-use, easy-to-use Allegro™ 3D biocontainer. This next generation ‘rocker’ bioreactor, designed for cultivation of mammalian cells in suspension culture, is equally suitable for applications ranging from general life sciences research to seed train operations and full Good Manufacturing Practice (GMP) production at the 2-to-20 liter scale.

The Pall XRS 20 Bioreactor System's unique bi-axial agitation properties improve cell culture perfor ...

The Pall XRS 20 Bioreactor System's unique bi-axial agitation properties improve cell culture performance. (Photo: Business Wire)

The XRS 20 System’s unique bi-axial agitation promotes better mixing and higher mass transfer, which expedites transport of nutrients and metabolites in the cellular micro-environment. This allows cultures to reach higher densities with overall greater viabilities, leading to significantly higher protein expression levels.

To ensure operational simplicity, the system includes the following features:

  • Allegro XRS 20 biocontainer with integrated components (sensors, filters, drain and tubing sets) for rapid installation and efficient harvesting
  • Advanced XRS 20 controller with touchscreen interface for easy monitoring and control of process parameters

A fully enclosed XRS 20 platform with interlock provides operator safety while protecting sensitive media components from light.

“The versatile, easy-to-use XRS 20 Bioreactor System combines state-of-the-art, single-use technology with advanced controls and features that improve cell culture performance,” said Ken Frank, President, Pall BioPharmaceuticals.

To learn more about the XRS 20 Bioreactor System please visit www.pall.com/bioreactors.

Pall Life Sciences

Pall Life Sciences provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotech drugs, vaccines and classic pharmaceuticals. The company’s membranes and membrane devices optimize detection and sample preparation in the drug research, clinical diagnostics, genomics, and proteomics markets. Pall is a leading provider of separation systems and single-use filtration and purification technologies to pharmaceutical and biotechnology companies to support faster development of new drugs and vaccines that are safer and require less energy and water to produce. Pall technologies are also used in clinical institutions and the food and beverage industries.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs